id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2020-0028-0007,DEA,DEA-2020-0028,Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV,Rule,,2021-06-02T04:00:00Z,2021,6,2021-06-02T04:00:00Z,,2021-08-18T13:34:04Z,2021-11512,0,0,0900006484b4cd8d
DEA-2020-0028-0002,DEA,DEA-2020-0028,Remimazolam DEA 658 8-factor,Supporting & Related Material,,2020-10-08T04:00:00Z,2020,10,,,2020-10-08T17:05:13Z,,0,0,09000064848ed460
DEA-2020-0028-0003,DEA,DEA-2020-0028,FINAL SIGNED ASH Response to DEA Remimazolam_04162020,Supporting & Related Material,,2020-10-08T04:00:00Z,2020,10,,,2020-10-08T19:19:33Z,,0,0,09000064848edc25
DEA-2020-0028-0001,DEA,DEA-2020-0028,Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV,Rule,,2020-10-06T04:00:00Z,2020,10,2020-10-06T04:00:00Z,2020-11-06T04:59:59Z,2020-11-07T02:00:38Z,2020-19313,0,0,09000064848dc25c